Import Celomide 25mg to USA | Ernest Oncology Bulk Pharma Distributor

Celomide 25mg Capsule: Advanced Immunomodulatory Therapy for Multiple Myeloma and MDS

Are you searching for a reliable Celomide 25 mg capsule exporter from India? Ernest Oncology, a premier division of Ernest Pharmaceutical Pvt. Ltd., is a leading global supplier and bulk distributor of specialized hematology treatments. We provide a robust supply chain to the UK (London), USA, UAE (Abu Dhabi), Australia, and South Africa, ensuring that high-intensity oncology medications reach healthcare providers and specialized pharmacies with speed and regulatory precision.

Detailed Product Overview: What is Celomide 25mg?

Celomide 25 mg is a high-strength oral antineoplastic medication containing the active ingredient Lenalidomide. It belongs to a specialized class of drugs known as Immunomodulatory Imides (IMiDs). Lenalidomide is a derivative of thalidomide but has been chemically engineered to be more potent and have a more favorable side-effect profile for the treatment of various blood-related cancers.

The 25 mg strength is the standard therapeutic starting dose for many intensive treatment protocols, particularly for newly diagnosed patients or those in the active induction phase of treatment for Multiple  Myeloma.

Primary Therapeutic Indications:

Celomide 25mg is clinically indicated for several complex conditions:

• Multiple Myeloma (MM): Used as a foundational therapy in combination with dexamethasone for both newly diagnosed patients and those who have received at least one prior therapy.

• Myelodysplastic Syndromes (MDS): Specifically for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality.

• Mantle Cell Lymphoma (MCL): For patients whose disease has relapsed or progressed after prior therapies.

• Follicular Lymphoma & Marginal Zone Lymphoma: Often used in combination with rituximab for previously treated adult patients.

Mechanism of Action: How Celomide 25mg Works: 

Celomide exerts its anti-cancer effects through a multi-pathway approach:

1. Direct Anti-Tumor Activity: It binds to the protein cereblon, which triggers the degradation of essential transcription factors, leading to cell cycle arrest and apoptosis (programmed cell death) in malignant cells.

2. Inhibition of Angiogenesis: It blocks the formation of new blood vessels that tumors need to grow and spread, essentially "starving" the cancer cells of nutrients and oxygen.

3. Immunomodulation: It enhances the activity of the patient’s own immune system, specifically increasing the number and activity of Natural Killer (NK) cells and T-cells to better identify and destroy cancer cells.

4. Microenvironment Alteration: It disrupts the support system within the bone marrow that myeloma cells rely on to survive.

Administration and Dosage: 

• Route: Administered orally (capsules).

• Standard Cycle: Often administered in 21-day or 28-day cycles (e.g., 21 days on, 7 days off).

• Instructions: Capsules must be swallowed whole with water at the same time each day. They should never be opened, chewed, or crushed.

Safety Profile & Safety Monitoring: 

Healthcare professionals must implement strict monitoring for patients on Celomide 25 mg:

• Embryo-Fetal Toxicity: Due to its structural similarity to thalidomide, it can cause severe birth defects. Strict adherence to pregnancy prevention programs (REMS) is mandatory.

• Hematologic Monitoring: Regular blood tests are required to monitor for Neutropenia (low white blood cells) and Thrombocytopenia (low platelets).

• Venous Thromboembolism: Patients are at an increased risk of blood clots; prophylactic anticoagulation is often recommended.

• Common Side Effects: Diarrhea, fatigue, nausea, and skin rashes.

Why Source Celomid 25 mg from Ernest Oncology?

• Verified Supply Chain: Direct procurement from GMP-certified facilities, ensuring 100% authenticity for every exporter from India shipment.

• Global Logistics Mastery: Expertise in handling international regulatory paper work USA, UK, UAE, Australia, and South Africa. 

• Bulk Supply Stability: We maintain a consistent inventory of 25mg capsules to ensure that global distributors can fulfill large hospital tenders without delay.

• B2B Partnership Focus: Specialized wholesale pricing and track-and-trace logistics for international pharmaceutical distributors.

•